Sanofi

European Commission Approves Sanofi’s Teizeild for Early Type 1 Diabetes

European Commission Approves Sanofi’s Teizeild for Early Type 1 Diabetes

13 Jan 2026

2 min read

US FDA Accepts Priority Review For Sanofi’s Tzield sBLA In Children With Stage 2 Type 1 Diabetes

US FDA Accepts Priority Review For Sanofi’s Tzield sBLA In Children With Stage 2 Type 1 Diabetes

06 Jan 2026

1 min read

Sanofi’s Wayrilz Becomes First BTK Inhibitor To Get European Approval For Immune Thrombocytopenia

Sanofi’s Wayrilz Becomes First BTK Inhibitor To Get European Approval For Immune Thrombocytopenia

27 Dec 2025

2 min read

Read More

Voice Of HealthCare

vohnetwork.com